Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedJun 07, 2026
DataAggregated Company Financials
Companies14
- 7D-0.1%
- 3M-5.9%
- 1Y-8.2%
- YTD-2.1%
Over the last 7 days, the Biotech industry has remained flat, although notably Bioceltix gained 6.3%. As for the longer term, the industry has declined 8.2% in the last year. Earnings are forecast to grow by 60% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 07 Jun 2026 | zł2.3b | zł378.6m | -zł178,433,028.00 | 58.2x | -13.1x | 6.2x |
| Tue, 05 May 2026 | zł2.0b | zł353.9m | -zł150,930,751.00 | 75.6x | -13.1x | 5.6x |
| Thu, 02 Apr 2026 | zł2.0b | zł353.9m | -zł150,930,751.00 | 80.2x | -13.1x | 5.6x |
| Sat, 28 Feb 2026 | zł2.0b | zł429.9m | -zł152,630,978.00 | 67.6x | -13.3x | 4.7x |
| Mon, 26 Jan 2026 | zł2.0b | zł427.5m | -zł155,672,238.00 | 49x | -12.7x | 4.6x |
| Wed, 24 Dec 2025 | zł1.8b | zł427.5m | -zł155,672,238.00 | 46.2x | -11.7x | 4.3x |
| Fri, 21 Nov 2025 | zł1.9b | zł427.7m | -zł158,415,044.00 | 44.1x | -11.8x | 4.4x |
| Sun, 19 Oct 2025 | zł1.9b | zł394.6m | -zł166,699,765.00 | 38.2x | -11.6x | 4.9x |
| Tue, 16 Sep 2025 | zł2.0b | zł400.7m | -zł143,324,812.00 | 42.2x | -13.8x | 4.9x |
| Thu, 14 Aug 2025 | zł2.1b | zł401.9m | -zł140,696,694.00 | 46.9x | -14.8x | 5.2x |
| Sat, 12 Jul 2025 | zł2.0b | zł401.8m | -zł140,766,468.00 | 33.1x | -14.5x | 5.1x |
| Mon, 09 Jun 2025 | zł2.0b | zł398.3m | -zł143,191,212.00 | 49.3x | -14.3x | 5.1x |
| Wed, 07 May 2025 | zł2.1b | zł396.8m | -zł112,335,193.00 | 53.9x | -18.8x | 5.3x |
| Fri, 04 Apr 2025 | zł2.0b | zł438.8m | -zł95,426,193.00 | 31x | -20.7x | 4.5x |
| Sun, 02 Mar 2025 | zł2.1b | zł438.6m | -zł94,885,631.00 | 29.8x | -21.7x | 4.7x |
| Tue, 28 Jan 2025 | zł2.0b | zł408.7m | -zł84,434,269.00 | 42.2x | -23.2x | 4.8x |
| Thu, 26 Dec 2024 | zł1.8b | zł408.7m | -zł84,434,269.00 | 39.5x | -21.4x | 4.4x |
| Sat, 23 Nov 2024 | zł1.9b | zł406.7m | -zł85,672,298.00 | 58.4x | -22.1x | 4.7x |
| Mon, 21 Oct 2024 | zł2.1b | zł438.7m | -zł64,845,969.00 | 62.4x | -32.8x | 4.8x |
| Wed, 18 Sep 2024 | zł2.1b | zł442.8m | -zł53,453,784.00 | 62.8x | -39.9x | 4.8x |
| Fri, 16 Aug 2024 | zł2.2b | zł443.9m | -zł63,570,104.00 | 74x | -33.9x | 4.9x |
| Sun, 14 Jul 2024 | zł2.2b | zł444.2m | -zł64,230,755.00 | 71x | -33.8x | 4.9x |
| Tue, 11 Jun 2024 | zł2.0b | zł439.7m | -zł90,277,755.00 | 71x | -22.6x | 4.6x |
| Thu, 09 May 2024 | zł2.2b | zł441.3m | -zł90,006,665.00 | 54.5x | -24.6x | 5x |
| Sat, 06 Apr 2024 | zł2.2b | zł432.0m | -zł73,964,007.00 | 61.4x | -29.7x | 5.1x |
| Mon, 04 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 57.5x | -31x | 5x |
| Wed, 31 Jan 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 86.6x | -40.6x | 5.4x |
| Fri, 29 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 87.3x | -40.6x | 5.4x |
| Sun, 26 Nov 2023 | zł2.6b | zł498.2m | -zł58,578,911.00 | 97.8x | -43.7x | 5.1x |
| Tue, 24 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 46.4x | -44.4x | 5.2x |
| Thu, 21 Sep 2023 | zł2.8b | zł514.2m | -zł61,851,678.00 | 52x | -45.3x | 5.5x |
| Sat, 19 Aug 2023 | zł2.8b | zł520.1m | -zł43,410,661.00 | 51.6x | -64.3x | 5.4x |
| Mon, 17 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 54.9x | -68.3x | 5.6x |
| Wed, 14 Jun 2023 | zł2.8b | zł517.3m | -zł42,548,721.00 | 62.4x | -66.7x | 5.5x |
Price to Earnings Ratio
-66.7x
Current Industry PE
- Investors are optimistic on the Polish Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.0x is lower than the industry's current PS ratio of 6.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 9.9% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -1.69% | |
| Healthcare | -0.81% | |
| Biotech | -0.12% | |
| Biotech | -0.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BCX Bioceltix | zł87.30 | 6.3% +zł28.8m | -18.1% | PB7.1x | |
| PUR Pure Biologics | zł2.34 | 26.1% +zł5.9m | -52.0% | PE-3.1x | |
| GMT Genomtec | zł5.18 | 3.6% +zł2.7m | -28.0% | PS4107.1x | |
| GEN Genomed Spólka Akcyjna | zł25.40 | 5.0% +zł1.6m | -2.3% | PE10.9x | |
| SCS Stem Cells Spin | zł0.39 | 8.3% +zł1.2m | 61.2% | PS247.3x |